Compare KB Financial Group, Inc. (KB) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KB Financial Group, Inc. vs McKesson Corporation — how do they compare? KB Financial Group, Inc. trades at $115.25 (market cap $38.56B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation is far larger — about 2.5× KB Financial Group, Inc.'s market cap, and KB Financial Group, Inc. pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| KB | MCK | |
|---|---|---|
Market Cap | $38.56B | $97.35B |
Sector | Financials | Health |
52-Week High | $123.25 | $995.69 |
52-Week Low | $77.50 | $659.01 |
Dividend Yield | 2.72% | 0.39% |
Enterprise Value | — | $101.98B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About KB Financial Group, Inc.
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
